PJP vs. HRTS
Compare and contrast key facts about Invesco Dynamic Pharmaceuticals ETF (PJP) and Tema Obesity & Cardiometabolic ETF (HRTS).
PJP and HRTS are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. PJP is a passively managed fund by Invesco that tracks the performance of the Dynamic Pharmaceuticals Intellidex Index. It was launched on Jun 23, 2005. HRTS is an actively managed fund by Tema. It was launched on Nov 20, 2023.
Performance
PJP vs. HRTS - Performance Comparison
Loading graphics...
PJP vs. HRTS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | -0.44% | 27.98% | 9.63% | 9.01% |
HRTS Tema Obesity & Cardiometabolic ETF | -4.55% | 23.93% | -4.30% | 14.97% |
Returns By Period
In the year-to-date period, PJP achieves a -0.44% return, which is significantly higher than HRTS's -4.55% return.
PJP
- 1D
- 3.04%
- 1M
- -3.96%
- YTD
- -0.44%
- 6M
- 12.79%
- 1Y
- 21.16%
- 3Y*
- 12.12%
- 5Y*
- 6.67%
- 10Y*
- 6.42%
HRTS
- 1D
- 2.94%
- 1M
- -6.67%
- YTD
- -4.55%
- 6M
- 10.36%
- 1Y
- 16.44%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PJP vs. HRTS - Expense Ratio Comparison
PJP has a 0.58% expense ratio, which is lower than HRTS's 0.75% expense ratio.
Return for Risk
PJP vs. HRTS — Risk / Return Rank
PJP
HRTS
PJP vs. HRTS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and Tema Obesity & Cardiometabolic ETF (HRTS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PJP | HRTS | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.12 | 0.86 | +0.27 |
Sortino ratioReturn per unit of downside risk | 1.58 | 1.27 | +0.31 |
Omega ratioGain probability vs. loss probability | 1.20 | 1.16 | +0.04 |
Calmar ratioReturn relative to maximum drawdown | 1.77 | 1.44 | +0.33 |
Martin ratioReturn relative to average drawdown | 5.03 | 4.11 | +0.92 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PJP | HRTS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.12 | 0.86 | +0.27 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.42 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.35 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.59 | 0.62 | -0.03 |
Correlation
The correlation between PJP and HRTS is 0.75, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
PJP vs. HRTS - Dividend Comparison
PJP's dividend yield for the trailing twelve months is around 1.02%, less than HRTS's 1.40% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | 1.02% | 0.98% | 0.97% | 1.01% | 0.95% | 0.81% | 0.75% | 0.77% | 1.12% | 0.65% | 0.91% | 5.49% |
HRTS Tema Obesity & Cardiometabolic ETF | 1.40% | 1.34% | 1.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
PJP vs. HRTS - Drawdown Comparison
The maximum PJP drawdown since its inception was -37.06%, which is greater than HRTS's maximum drawdown of -25.81%. Use the drawdown chart below to compare losses from any high point for PJP and HRTS.
Loading graphics...
Drawdown Indicators
| PJP | HRTS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.06% | -25.81% | -11.25% |
Max Drawdown (1Y)Largest decline over 1 year | -11.68% | -11.01% | -0.67% |
Max Drawdown (5Y)Largest decline over 5 years | -17.51% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -33.95% | — | — |
Current DrawdownCurrent decline from peak | -5.83% | -8.03% | +2.20% |
Average DrawdownAverage peak-to-trough decline | -8.90% | -9.12% | +0.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.88% | 3.86% | +1.02% |
Volatility
PJP vs. HRTS - Volatility Comparison
Invesco Dynamic Pharmaceuticals ETF (PJP) has a higher volatility of 6.62% compared to Tema Obesity & Cardiometabolic ETF (HRTS) at 5.96%. This indicates that PJP's price experiences larger fluctuations and is considered to be riskier than HRTS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PJP | HRTS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.62% | 5.96% | +0.66% |
Volatility (6M)Calculated over the trailing 6-month period | 11.57% | 11.22% | +0.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.11% | 19.25% | -0.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.97% | 19.28% | -3.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.42% | 19.28% | -0.86% |